Aurobindo Pharma secures USFDA approval for Glycerol Phenylbutyrate Oral Liquid EP News Bureau Apr 17, 2026 Company to launch product for urea cycle disorders with market size of US$ 50.2 million
Lupin launches authorised generic version of Ravicti in the United States EP News Bureau Oct 24, 2025 Lupin Limited announces the launch of Glycerol Phenylbutyrate Oral Liquid, 1.1g/mL, for chronic management of urea cycle disorders…
